LOGIN
Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement
December 2020
Local TXA Reduces Blood Loss vs Intravenous TXA in Patients Undergoing Total Hip Replacement
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Better Treatment Values in Local Application of Tranexamic Acid (TXA) than Intravenous Application with the Same Dose in Total Hip Arthroplasty.
Adv Ther. 2020 Oct;37(10):4346-4355.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy-two patients scheduled for a primary, unilateral total hip replacement were randomized to receive a local administration of tranexamic acid (TXA) or intravenous administration of TXA at the same dosage. Outcomes of interest included the following: total blood loss, hidden blood loss, incidence of blood transfusion, hematocrit (Hct) and hemoglobin (Hb) levels, C-reactive protein (CRP) and i...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.